BUSINESS● LOW2h ago · Oct 29, 2026, 10:13 AM
Eli Lilly is about to report earnings. Here's what to expect
CNBC · global
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS14m agoInitial jobless claims unexpectedly slip to 194K in past weekSeeking Alpha TechBUSINESS15m agoRapide Group signs LoI to acquire Indonesian Commodities BusinessSeeking Alpha Tech